Synonyms:
Status: Phase 2
Entry Type: Antibody

Pharmacology

Action Mechanism of Action Reference
INHIBITOR Proepiregulin inhibitor

Indications

Mesh Heading Maximum Phase Mesh ID Reference
Neuralgia 2 D009437 ClinicalTrials
Low Back Pain 2 D017116 ClinicalTrials
Osteoarthritis 2 D010003 ClinicalTrials
Diabetic Nephropathies 1 D003928 ClinicalTrials

Cross References

Resources Reference
ChEMBL CHEMBL4594573